4507 塩野義薬

累計 / 通期：4Q / 3Q / 2Q / 1Q

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/03	4Q	499,677	166,725	33.4%	-	-	205,159	41.1%	241.11	14.0%	6.5%	0.0%	20.4%
2025/03	4Q	438,268	156,603	35.7%	-	-	170,435	38.9%	200.36	0.7%	2.1%	0.0%	5.2%
2024/03	4Q	435,081	153,310	35.2%	-	-	162,030	37.2%	558.51	2.0%	2.9%	0.0%	-12.4%
2023/03	4Q	426,684	149,003	34.9%	-	-	184,965	43.3%	621.31	27.3%	35.1%	0.0%	62.0%
2022/03	4Q	335,138	110,312	32.9%	-	-	114,185	34.1%	378.75	12.8%	-6.1%	0.0%	2.1%
2021/03	4Q	297,177	117,438	39.5%	-	-	111,858	37.6%	365.03	-11.3%	-6.2%	-100.0%	-7.8%
2020/03	4Q	334,958	125,231	37.4%	151,751	45.3%	121,295	36.2%	392.80	-7.9%	-9.6%	-8.9%	-8.6%
2020/03	4Q	333,371	130,628	39.2%	-	-	122,193	36.7%	395.71	-8.3%	-5.7%	-100.0%	-8.0%
2019/03	4Q	363,721	138,537	38.1%	166,575	45.8%	132,759	36.5%	424.31	-	-	-	-

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/03	4Q	499,677	166,725	33.4%	-	-	205,159	41.1%	241.11	14.0%	6.5%	0.0%	20.4%
2025/03	4Q	438,268	156,603	35.7%	-	-	170,435	38.9%	200.36	0.7%	2.1%	0.0%	5.2%
2024/03	4Q	435,081	153,310	35.2%	-	-	162,030	37.2%	558.51	2.0%	2.9%	0.0%	-12.4%
2023/03	4Q	426,684	149,003	34.9%	-	-	184,965	43.3%	621.31	27.3%	35.1%	0.0%	62.0%
2022/03	4Q	335,138	110,312	32.9%	-	-	114,185	34.1%	378.75	12.8%	-6.1%	0.0%	2.1%
2021/03	4Q	297,177	117,438	39.5%	-	-	111,858	37.6%	365.03	-10.9%	-10.1%	0.0%	-8.5%
2020/03	4Q	333,371	130,628	39.2%	-	-	122,193	36.7%	395.71	-8.3%	-5.7%	-100.0%	-8.0%
2020/03	4Q	334,958	125,231	37.4%	151,751	45.3%	121,295	36.2%	392.80	-7.9%	-9.6%	-8.9%	-8.6%
2019/03	4Q	363,721	138,537	38.1%	166,575	45.8%	132,759	36.5%	424.31	-	-	-	-